Details of the Drug Reposition

General Information of This Drug (ID: DMCT4BA)

Drug Name
DMUC-5754A   DMCT4BA
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Peritoneal cancer DISYX23I 2C51.Z Phase 1 [1]
Ovarian cancer DISZJHAP 2C73 Phase 1 [1]
Fallopian tube cancer DISXHWCS 2C74 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01335958) Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer. U.S. National Institutes of Health.